HOME >> BIOLOGY >> NEWS
Blocking neurodegeneration by radiation and bone marrow transfer prevents inherited glaucoma in mice

Bar Harbor, Maine In a discovery that could point to new treatments for a wide range of neurodegenerative diseases, Jackson Laboratory researchers have found that high-dose radiation and bone marrow transfer treatments on glaucoma-susceptible mice completely blocked the development of glaucoma, by preventing neurodegeneration.

Glaucomas are among the most common neurodegenerative diseases, and a leading cause of blindness in the United States. Many patients with glaucoma have high intraocular pressure (IOP), long believed to be a cause of the degeneration of the optic nerve and nerve cells in the retina that leads to vision loss. The standard treatment for glaucoma is reducing the intraocular pressure by medication or surgery.

However, researchers have also observed that some patients with elevated IOP do not develop optic nerve and retinal damage, while others do incur damage despite relatively normal IOP. "It's increasingly clear," says Dr. Simon W.M. John, leader of the Jackson Laboratory research team and a Howard Hughes Medical Institute Investigator, "that multiple mechanisms are at work in this disease."

John and researchers elsewhere have identified several genes associated with glaucomas. They have also developed inherited mouse glaucoma models that reliably develop glaucoma in mid-life. One of these models is the DBA/2J mouse.

The Jackson research team treated 5- to 8-week-old DBA/2J mice with a single, high dose of gamma radiation, together with bone marrow transfer.

When they examined the mice at 12-14 months--an age at which most DBA/2J mice have advanced glaucoma--the researchers were amazed to find that the vast majority of mice did not have glaucoma. There was no detectable loss of the retinal ganglion cells, which typically degenerate in glaucoma.

"It was very surprising and we had to be very careful," John said. "We repeated the experiment two more times with the same results."

The research p
'"/>

Contact: Joyce Peterson
joyce@jax.org
207-288-6058
Jackson Laboratory
10-Mar-2005


Page: 1 2

Related biology news :

1. Blocking beta1-integrin to treat cancer
2. Blocking a premature aging syndrome with anticancer drugs
3. Blocking blood vessels provides new option for large group of advanced lung cancer patients
4. Blocking COX-1 slows tumor growth in mice
5. Blocking PLK-1 to beat bladder cancer
6. Blocking cell signaling can stymie viral infections, study shows
7. Blocking cell suicide switch fails to stop prion damage in mouse brains
8. Early environmental exposure may accelerate age-related neurodegeneration
9. Enhanced environment restores memory in mice with neurodegeneration
10. Salk and Stanford teams join forces to reveal two paths of neurodegeneration
11. Transcription factor proteins role in cell death, neurodegeneration and schizophrenia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/30/2019)... ... September 30, 2019 , ... USDM ... capacity of life science organizations to accelerate innovation and maximize productivity, announces that ... 4th. , What: Just 30 days to 21 CFR Part 11 compliance with ...
(Date:9/25/2019)... ... September 25, 2019 , ... ... TX, have placed over 20,000 dental implants for a variety of procedures, including ... zygomatic and pterygoid dental implants. Dental implants offer patients permanent tooth ...
(Date:9/24/2019)... , ... September 23, 2019 , ... ... in Cambridge, MA, announce today that Holotype HLA and other Omixon products will ... of the American Society for Histocompatibility and Immunogenetics (ASHI) in Pittsburgh, ...
Breaking Biology News(10 mins):
(Date:10/8/2019)... ... 08, 2019 , ... As Keck Graduate Institute (KGI) students ... executives with a set of recommendations to enhance supply chain processes. Now the ... TMP to a wider audience of industry leaders attending the 12th Annual Bio ...
(Date:10/3/2019)... ... October 02, 2019 , ... Today marked ... that is enabling clinical program outsourcing success by cultivating radical improvements in leadership, ... biotech veteran executive Brenda Reese, phaseUP™ brings clients deep, broad and unique expertise ...
(Date:9/30/2019)... WOODLANDS, Texas (PRWEB) , ... September 30, 2019 ... ... , the materials science newsletter from Rigaku Corporation , is now available ... techniques related to X-ray based materials science, including X-ray diffraction, fluorescence and imaging, ...
(Date:9/24/2019)... ... September 24, 2019 , ... The Grain Foods Foundation is ... Advisory Board. Dr. Holscher is an Assistant Professor of Nutrition in the Department ... the University of Illinois Urbana-Champaign, where she has affiliate appointments with the Institute ...
Breaking Biology Technology:
Cached News: